UNSPSC 51285905: Etisomicin

This classification denotes an antibiotic with the molecular formula C20H39N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0BZK9FE5DE, chemically known as o-3-deoxy-3-(ethylamino)-4-c-methyl-beta-l-arabinopyranosyl-(1->4)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1->6))-2-deoxy-l-streptamine. but more generally known as etisomicin, which bears US NIH Compound Identifier 216268.

European Medicines Agency schedules Etisomicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07311MIG. The term ETISOMICIN is an International Non-Proprietary Name. ETISOMICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1C(O)C(OC2OC(=CCC2N)CN)C(N)CC1N)C1OCC(O)(C(NCC)C1O)C.

UNSPSC 51285905 Etisomicin, a Commodity code, shows minimal relevant recent activity in state and local procurement. The code nominally describes a specific antibiotic pharmaceutical, but the recent opportunities tagged under it address broader pharmaceutical and medical supply procurement—naloxone and drug deactivation systems, generic multi-source pharmaceuticals through cooperative purchasing, direct-to-manufacturer prescription programs, and medical and first aid supplies for emergency response. None of these opportunities explicitly solicit etisomicin or directly match the code's intended scope. The issuing bodies include a county health department (Seminole County, Florida), a state health commission (Texas HHS), a city fire department (Tampa), and a multistate cooperative purchasing alliance (MMCAP, administered by Minnesota). The geographic spread spans Florida, Texas, and the Upper Midwest, with MMCAP serving multiple participating states including Oregon.

Representative recent opportunities illustrate the mismatch. Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 drug deactivation systems annually with response due July 26, 2023 (an apparent data inconsistency in the source). The City of Tampa issued IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies including respiratory equipment, cardiac monitoring electrodes, and consumables for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and response due March 13, 2026; this procurement is sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. MMCAP released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with response due March 26, 2026. The Texas HHS RFI HHS0017013, posted April 3, 2026, seeks vendor capabilities for direct-to-manufacturer prescription programs but is exploratory in nature. None of these solicitations directly align with etisomicin procurement, suggesting the code shows little actionable recent activity for vendors in the antibiotic pharmaceutical space.